How does a predictive low glucose suspend (PLGS) system tackle pediatric lifespan challenges in diabetes treatment? Real world data analysis.

Objectives: The aim of the study was to assess the benefits of a predictive low glucose suspend (PLGS) system in real-life in children and adolescents with type 1 diabetes of different age and age-related clinical challenges.

Methods: Real life retrospective and descriptive analysis included 44 children (26 girls) with type 1 diabetes who were introduced to PLGS system. We divided them in three age groups: I (3-6 years old, n = 12), II (7-10 y/o, n = 16), III (11-19 y/o, n = 16).

How modern technologies improve daily diabetic control.

Introduction: Diabetic children who live surrounded by modern technologies such as Facebook, Google, and GPS want their treatment to stand up to the times, especially if it accompanies them for their whole life.

Aim Of The Study: In this review we aim to analyse which technologies help diabetics in their everyday struggle to keep up with diabetes as well as whether those inventions catch up to the reality of 21st century.

Material And Methods: We decided to discuss the most outstanding inventions in the field of diabetology.